Arm is hard to justify over Nvidia, which is cheaper and growing faster. Arm trades at 44x sales and 112x earnings with 28% two-year sales growth and 32% EPS growth, while Nvidia trades at 11x sales and 20x earnings with 60%+ growth in both. There is more to an investment case than these figures. x.com 

Cadence's IBD composite and EPS ratings of 90 support its standing as arguably the best in the 'making chips better' group after ASML. The screen estimates 2026 EPS growth of 18% and sales growth of 21%. Its chart is near a breakout after a long pullback. x.com 

Arm's low blended royalties leave pricing and mix leverage that makes earnings look massively understated at 110x forward P/E. It collects about 7 cents per chip overall, versus $1 on compute and networking chips and $0.85-$0.90 on smartphones. An 8-cent bump to 15 cents per chip is a hypothetical $5-6 billion royalty-revenue scenario, which would be pure cash. Mix shift and price increases are coming, though royalties may not double. x.com  x.com 

Demand for chip-design software is booming, making Synopsys the chip-design name to own after Cadence's results. Cadence reported a record $8.2 billion backlog and raised its 2026 revenue-growth outlook to 21%; Synopsys is still about 12% below its May high, and all four models signal Long on Synopsys versus Flat on Cadence. x.com 

Arm Holdings is expensive against its earnings, trading at 92x forward earnings versus a typical 38x for chipmakers. At 38x next year's $3.05 EPS, fair value runs roughly $102-$130, so at $281.30 buyers pay about 116% over fair value. This is a levels-only view from reported earnings and revenue estimates, with no fundamental work. x.com 

Arm is well positioned in the AI CPU stack as agentic AI drives massive CPU demand and x86 loses ground. Its new AGI CPU, its first production silicon, comes with a five-year goal of about $15 billion in chip revenue, $25 billion total and more than $9 in EPS, roughly 38% annual growth, though meaningful revenue is not expected until fiscal 2028. Royalties from third-party CPUs like Nvidia's Vera add another path. That TAM expansion could take out its roughly $185 all-time high within two years. … Show more

Arm is heavily overvalued: at about $240B it trades above 100x forward P/E and roughly 50x sales, already pricing in about 26x earnings five years out. That rests on FY2031 targets of $25B revenue, $15B of it from its own AGI CPU silicon starting from zero, and $9.00 EPS. Momentum is real, with Q1 revenue up 22% and the AGI CPU order book doubling to $2B+. But chip sales dilute ~98% IP gross margins to ~40-50%, and reliance on TSMC wafers adds execution risk the multiple leaves no room for. … Show more

Arm is still expensive at about 40x revenue with only 20% growth, so it has not fallen enough. x.com 

Arm collects royalties across the CPUs that AI workloads increasingly need, including AWS Graviton5, Google Axion, Azure Cobalt 200, Nvidia Grace and Vera, Qualcomm's Dragonfly C1000 and nearly all leading DPUs and SmartNICs. Anthropic locked in $11.6B over seven years with Akamai, expandable to about $20B, specifically for CPU workloads. x.com  x.com 

Arm Holdings is way overvalued at a $450B market cap on $6B of revenue. That is about 80x sales for a slow-growth company that is primarily a smartphone chip business, a multiple a forward-looking market wouldn't pay. It looks overvalued even relative to SpaceX. x.com  x.com  x.com  x.com